Charles River Laboratories International (MIL:1CRL) Cyclically Adjusted PS Ratio: (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:1CRL Charles River Laboratories International Inc MIL:1CRL
69 GF Score
Price €143.90
GF Value €124.51
! 8 Warning Signs
View Full Analysis

What is Charles River Laboratories International Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Charles River Laboratories International  (MIL:1CRL) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Charles River Laboratories International Cyclically Adjusted PS Ratio Related Terms


Charles River Laboratories International Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Charles River Laboratories International's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Charles River Laboratories International Cyclically Adjusted PS Ratio Chart

Charles River Laboratories International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.40 4.15 3.99 2.83 2.81

Charles River Laboratories International Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.25 2.21 2.23 2.81 2.35

MIL:1CRL vs RVTY, QGEN, ICLR: Cyclically Adjusted PS Ratio Comparison

For the Diagnostics & Research subindustry, Charles River Laboratories International's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Charles River Laboratories International Cyclically Adjusted PS Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Charles River Laboratories International's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Charles River Laboratories International's Cyclically Adjusted PS Ratio falls into.


MIL:1CRL
69GF Score
Charles River Laboratories International Inc MIL:1CRL
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Charles River Laboratories International Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Charles River Laboratories International's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Charles River Laboratories International's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=17.503/330.2130*330.2130
=17.503

Current CPI (Mar. 2026) = 330.2130.

Charles River Laboratories International Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 8.062 241.018 11.046
201609 7.897 241.428 10.801
201612 9.158 241.432 12.526
201703 8.608 243.801 11.659
201706 8.637 244.955 11.643
201709 8.049 246.819 10.769
201712 8.262 246.524 11.067
201803 8.205 249.554 10.857
201806 10.216 251.989 13.387
201809 10.169 252.439 13.302
201812 10.853 251.233 14.265
201903 10.817 254.202 14.051
201906 11.718 256.143 15.107
201909 12.200 256.759 15.690
201912 12.468 256.974 16.021
202003 12.806 258.115 16.383
202006 12.063 257.797 15.452
202009 12.446 260.280 15.790
202012 12.667 260.474 16.058
202103 13.561 264.877 16.906
202106 14.788 271.696 17.973
202109 14.771 274.310 17.781
202112 15.517 278.802 18.378
202203 16.168 287.504 18.570
202206 17.951 296.311 20.005
202209 19.481 296.808 21.674
202212 20.220 296.797 22.497
202303 18.695 301.836 20.453
202306 19.009 305.109 20.573
202309 18.640 307.789 19.998
202312 18.107 306.746 19.492
202403 17.951 312.332 18.979
202406 18.386 314.175 19.325
202409 17.638 315.301 18.472
202412 18.637 315.605 19.500
202503 17.902 319.799 18.485
202506 18.145 322.561 18.575
202509 17.322 324.800 17.611
202512 17.252 324.054 17.580
202603 17.503 330.213 17.503

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Charles River Laboratories International (MIL:1CRL) Overvalued in 2026?

Based on GuruFocus' analysis, Charles River Laboratories International stock appears to be overvalued. The current stock price of €143.90 is trading 15.6% above its estimated GF Value™ of €124.51.

Key valuation signals for MIL:1CRL:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €124.51 vs. price of €143.90 (15.6% above fair value)
  • GF Score™: 69/100 with 8 warning signs

No single metric tells the full story. See the MIL:1CRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Charles River Laboratories International Business Description

Other Exchanges CRL:USARV6:Germany
Address 251 Ballardvale Street, Wilmington, MA, USA, 01887
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
69GF Score

Get the complete analysis for MIL:1CRL

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€143.90
Price
€124.51
GF Value